Advertisement

Pharmacy World and Science

, Volume 26, Issue 4, pp 191–192 | Cite as

Use of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema

  • Sabine A. Fuchs
  • Ronald H.B. Meyboom
  • Eugène P. van Puijenbroek
  • Henk-Jan GuchelaarEmail author
Article
ACE inhibitors Adverse effect Angioedema 

References

  1. 1.
    Granger CB, McMurray JJV, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function intolerant to angiotensin-converting-enzym inhibitorsthe CHARM-Alternative trial. Lancet 2003;362: 772–6.Google Scholar
  2. 2.
    van Rijnsoever EW, Kwee-Zuiderwijk WJM, Feenstra J. Angioneurotic edema attributed to the use of losdartan. Arch Intern Med1998; 158: 2063–5.Google Scholar
  3. 3.
    Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996; 36: 281–306.Google Scholar
  4. 4.
    Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carratero UA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 1926–35.Google Scholar
  5. 5.
    Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349–55.Google Scholar
  6. 6.
    Vleerning W, Stricker C, de Wildt DJ, van Amsterdam JG. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18: 171–88.Google Scholar
  7. 7.
    Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor induced angioedema. Ann Pharmacother 2000; 34: 526–8.Google Scholar
  8. 8.
    Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 2002; 25: 73–6.Google Scholar
  9. 9.
    Fuchs SA, Koopmans RP, Guchelaar HJ, Brodie-Meijer CC, Meyboom RH. Are angiotensin II receptor antagonists safe in patients with previous angiotensin-converting enzyme inhibitorinduced angioedema? Hypertension 2001; 37: E1.Google Scholar
  10. 10.
    Abdi R, Dong VM, Lee CJ, Ntuso KA. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy 2002; 22: 1173–5.Google Scholar
  11. 11.
    Touraud JP, Collet E, Louguet C, Sgro C, Dalac S, Dutronc Y, Lambert D. Cross-sensitivity between angiotensin-converting enzyme inhibitor and angiotensin II receptor antagonist. Ann Dermatol Venereol 2002; 129: 1033–6.Google Scholar
  12. 12.
    de Paz S, Martin AB, Iglesias A, Dominguez AR. Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Med Clin 1999; 113: 759.Google Scholar
  13. 13.
    Lo KS. Angioedema associated with candesartan. Pharmacotherapy 2002; 22: 1176–9.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Sabine A. Fuchs
    • 1
  • Ronald H.B. Meyboom
    • 2
    • 3
  • Eugène P. van Puijenbroek
    • 4
  • Henk-Jan Guchelaar
    • 5
    • 5
    Email author
  1. 1.Department of PediatricsUniversity Medical Center UtrechtUtrechtThe Netherlands
  2. 2.The WHO Uppsala Monitoring CenterUppsalaSweden
  3. 3.Department of Pharmacoepidemiology and PharmacotherapyUtrecht Institute for Pharmaceutical Sciences (UIPS)UtrechtThe Netherlands
  4. 4.Netherlands Farmacovigilance Centre Lareb’s-HertogenboschThe Netherlands
  5. 5.Department of Clinical Pharmacy & ToxicologyLeiden University Medical CenterLeidenThe Netherlands

Personalised recommendations